检索

期
标题
作者
卷 27, 编号 2 (2025)
Renal cell carcinoma associated with von Hippel–Lindau syndrome: an ambispective study
Volkova M., Turupaev K., Filippova M., Ladyko D., Sinitsyna O., Gridneva Y., Matveev V.
PDF
(Rus)
卷 27, 编号 2 (2025)
Diagnosis of renal cell carcinoma in patients with prostate cancer: capabilities of PET/CT with 18F-PSMA-1007
Ognerubov N., Mirsalimova O., Antipova T.
PDF
(Rus)
卷 16, 编号 3 (2014)
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.
卷 24, 编号 2 (2022)
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M., Turupaev K., Kalinin S.
PDF
(Rus)
卷 26, 编号 3 (2024)
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
Pokataev I., Stroyakovskiy D., Fedyanin M., Zhukova L., Stativko O., Andreyashkina I., Volkova M., Volkonskiy M., Polshina N., Kotova E., Kravchuk D., Bystrov A., Antonova T., Lyadova M., Kuzmina E., Parts S., Salpagarov M., Galkin V., Klimov A.
PDF
(Rus)
卷 11, 编号 3 (2009)
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Matveev V.
卷 23, 编号 4 (2021)
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
PDF
(Rus)
卷 11, 编号 2 (2009)
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Podregul'skiy K.
卷 22, 编号 3 (2020)
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N., Antipova T., Gumareva G.
PDF
(Rus)
卷 17, 编号 4 (2015)
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P., Orlova R., Shkolnik M., Karlov P.
卷 26, 编号 3 (2024)
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
Pokataev I., Stativko O., Volkova M., Fedorova A., Zueva E., Ibragimova M., Tsareva E., Antonova T., Sinitsyna O., Cherniaev V., Gridneva Y., Oskarev A., Galkin V.
PDF
(Rus)
卷 16, 编号 3 (2014)
Targeted therapy for metastatic renal cell carcinoma
Porta C., Tsimafeyev I.
卷 25, 编号 2 (2023)
Updates in urologic oncology guidelines: renal cell carcinoma. A review
Volkova M., Nosov D., Alekseev B.
PDF
(Rus)
卷 25, 编号 2 (2023)
Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study
Volkova M., Kalpinskiy A., Menshikov K., Gorbuleva L., Sultanbaev A., Evsyukova O., Meltonian V., Mishugin S., Maturov M., Olshanskaya A., Shemetov D., Sannikova T., Makhnutina M., Filipieva M., Gaijsina E., Ovchinnikova E., Mailian O., Alekseev B., Matveev V.
PDF
(Rus)
卷 15, 编号 4 (2013)
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A., Ivanov S.
卷 24, 编号 2 (2022)
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review
Zukov R., Chernyaev D., Zulkaidarova A.
PDF
(Rus)
卷 15, 编号 3 (2013)
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.
1 - 17 的 17 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语